GnRH Antagonist Versus GnRH Agonist in Polycystic Ovary Syndrome During in Vitro Fertilization - Embryo Transfer
Status:
Completed
Trial end date:
2016-12-31
Target enrollment:
Participant gender:
Summary
GnRH (Gonadotropin-releasing hormone) antagonists in IVF (in vitro fertilization) has been
accomplished by several randomized controlled trials compared with conventional GnRH agonist
long protocol in polycystic ovary syndrome (PCOS) patients. Moreover, there are debating
issues that refer to the timing of GnRH antagonist initiation. The purpose of this study is
to investigate the laboratory and clinical priority during ovarian stimulation for IVF in
patients with PCOS treated with three different protocols.